Allarity Therapeutics announced that their drug stenoparib achieved a significant milestone in a Phase 2 clinical trial for the treatment of ovarian cancer.
AI Assistant
ALLARITY THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.